세계의 자동 NGS 라이브러리 준비 시장 : 규모, 점유율, 동향 분석(제품별, 유형별, 워크플로우별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Automated NGS Library Preparation Market Growth & Trends:

The global automated NGS library preparation market size is anticipated to reach USD 1,453.8 million by 2030 and is projected to grow at a CAGR of 13.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for high-throughput sequencing and the need for efficient and reproducible sample preparation is driving the growth of automated NGS library preparation technologies. These advancements enhance workflow efficiency, minimize human errors, and provide scalability for various genomic applications, including clinical diagnostics, oncology research, and drug discovery.

The COVID-19 pandemic further accelerated the adoption of automated NGS library preparation solutions as laboratories worldwide sought streamlined and scalable sequencing workflows. The surge in genomic surveillance and infectious disease research during the pandemic emphasized the need for automation of sample preparation. Moreover, collaborations between research institutions, biotechnology companies, and healthcare providers led to significant technological advancements, boosting the market's expansion.

In addition, the rising availability of automated NGS library preparation services has further fueled market growth. Contract research organizations (CROs) and Contract Manufacturing Organizations (CMOs) are essential in supporting the development and commercialization of sequencing-based applications. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, facilitating faster and more cost-effective deployment of automated NGS solutions. Automation is becoming increasingly essential as the demand for NGS expands across various fields.

However, integrating automation into NGS library preparation workflows can be complex, involving challenges like equipment compatibility, software integration, and protocol adaptation. It also requires training personnel to manage and maintain advanced systems. Despite these hurdles, successful implementation offers substantial benefits, including enhanced scalability, minimized errors, and increased throughput-positioning automation as a strategic investment for laboratories aiming to stay competitive in the fast-evolving genomics space.

Automated NGS Library Preparation Market Report Highlights:

• The kits & reagents segment accounted for the largest market revenue share in 2024, owing to their recurring demand, ease of use, and critical role in ensuring workflow consistency. The growing adoption of automated platforms further boosted reagent consumption. However, the instruments segment is expected to grow at the fastest CAGR over the forecast period.
• Based on type, the targeted genome sequencing segment led the market with the largest revenue share of 45.76% in 2024, driven by its cost-effectiveness, high accuracy, and growing use in clinical and diagnostic applications. On the other hand, the whole genome sequencing segment is anticipated to witness at the fastest CAGR of 14.58% over the forecast period.
• Based on workflow, the nucleic acid extraction segment accounted for the largest market revenue share in 2024, owing to its foundational role in sequencing protocols and the high demand for reliable, high-quality sample preparation across applications. On the other hand, the fragmentation segment is expected to grow at the fastest CAGR during the forecast period.
• Based on application, the drug & biomarker discovery segment accounted for the largest market revenue share in 2024. This is attributed to the rising use of NGS in precision medicine, target identification, and companion diagnostics development. However, the disease diagnostics segment is projected to grow at the fastest CAGR over the forecast period.
• Based on end use, the pharmaceutical and biotechnology companies segment accounted for the largest market revenue share in 2024. The growth is due to increased investment in genomics research, drug development, and the adoption of automated sequencing technologies to accelerate R&D workflows. On the other hand, the academic and research institutions segment is expected to register at the fastest CAGR during the projected period.
• North America dominated the market with the largest revenue share in 2024, owing to factors such as strong presence of key market players, advanced healthcare infrastructure, significant R&D investments, and high adoption of genomic technologies. Asia Pacific region is expected to grow at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Application
  • 1.2.4. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Automated NGS Library Preparation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Demand for High-Throughput Sequencing
    • 3.2.1.2. Advancements in Automation and Robotics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Cost of Automation Systems
    • 3.2.2.2. Complexity of Workflow Integration
• 3.3. Automated NGS Library Preparation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Automated NGS Library Preparation Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Automated NGS Library Preparation Market Product Movement Analysis
• 4.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Kits & Reagents
  • 4.5.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.2. DNA Library Preparation Kits
    • 4.5.2.1. DNA Library Preparation Kits Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. RNA Library Preparation Kits
    • 4.5.3.1. RNA Library Preparation Kits Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Exome/Targeted Capture Library Preparation Kits
    • 4.5.4.1. Exome/Targeted Capture Library Preparation Kits Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Automated NGS Library Preparation Market: Type Estimates & Trend Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Automated NGS Library Preparation Market Type Movement Analysis
• 5.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Targeted Genome Sequencing
  • 5.4.1. Targeted Genome Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Whole Genome Sequencing
  • 5.5.1. Whole Genome Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.6. Whole Exome Sequencing
  • 5.6.1. Whole Exome Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.7. Other Sequencing Types
  • 5.7.1. Other Sequencing Types Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Automated NGS Library Preparation Market: Workflow Estimates & Trend Analysis

• 6.1. Workflow Segment Dashboard
• 6.2. Global Automated NGS Library Preparation Market Workflow Movement Analysis
• 6.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 6.4. Nucleic Acid Extraction
  • 6.4.1. Nucleic Acid Extraction Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.5. Fragmentation
  • 6.5.1. Fragmentation Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.6. Adapter Ligation
  • 6.6.1. Adapter Ligation Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.7. Purification & Quantification
  • 6.7.1. Purification & Quantification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. Automated NGS Library Preparation Market: Application Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Automated NGS Library Preparation Market Application Movement Analysis
• 7.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Drug & Biomarker Discovery
  • 7.4.1. Drug & Biomarker Discovery Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
• 7.5. Disease Diagnostics
  • 7.5.1. Disease Diagnostics Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 7.5.2. Cancer Diagnostics
    • 7.5.2.1. Cancer Diagnostics Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. Reproductive Health Diagnostics
    • 7.5.3.1. Reproductive Health Diagnostics Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. Infectious Disease Diagnostics
    • 7.5.4.1. Infectious Disease Diagnostics Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. Other Disease Diagnostic Applications
    • 7.5.5.1. Other Disease Diagnostic Applications Market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)

Chapter 8. Automated NGS Library Preparation Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Automated NGS Library Preparation Market End Use Movement Analysis
• 8.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Hospitals and Clinics
  • 8.4.1. Hospitals and Clinics Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.5. Academic and Research Institutions
  • 8.5.1. Academic and Research Institutions Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.6. Pharmaceutical and Biotechnology Companies
  • 8.6.1. Pharmaceutical and Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.7. Other
  • 8.7.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 9. Automated NGS Library Preparation Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Company Market Position Analysis, 2024
• 10.3. Strategy Mapping
• 10.4. Participants Overview
  • 10.4.1. Illumina, Inc.
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Agilent Technologies, Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. QIAGEN N.V.
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. F. Hoffmann-La Roche Ltd
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Bio-Rad Laboratories, Inc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Revvity
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Oxford Nanopore Technologies Ltd.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Pacific Biosciences of California, Inc.
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Hamilton Company
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives